ReviewFrontiers in gastroenterology (Lausanne, Switzerland)2025

New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions.

Lan Valerie Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.